Effects of demethylating agent 5-aza-2′-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines

Jun Murakami, Jun-Ichi Asaumi, Yuu Maki, Hidetsugu Tsujigiwa, Masahiro Kuroda, Noriyuki Nagai, Yoshinobu Yanagi, Tetsuyoshi Inoue, Shoji Kawasaki, Noriaki Tanaka, Nagahide Matsubara, Kanji Kishi

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Maspin, which belongs to the serine protease inhibitor (serpin) superfamily, has been proposed as a potent tumor suppressor that inhibits cell motility, invasion, angiogenesis, and metastasis. In the present study, we examined the effects of 5-aza-2-deoxycytidine (5-aza-dC), a demethylating agent, and FR901228, a histone deacetylase (HDAC) inhibitor, on maspin expression in oral cancer cell lines. The expression levels of maspin mRNA were divided into two groups, which was the maspin low-expressed and high-expressed cell lines in the 12 oral cancer cell lines. The maspin promoter contained only a few methylated CpG sites in the maspin low-expressed cell lines. Moreover, the methylation status was not altered after 5-aza-dC treatment. However, the transcription of the maspin gene was clearly increased following 5-aza-dC treatment in a number of oral cancer cell lines. These results imply that an action of 5-aza-dC is separate from induction of promoter demethylation. Treatment with FR901228 resulted in a time-dependent stimulation of the re-expression of maspin mRNA as early as 4 h after treatment in the maspin downregulated cells. The re-expression of the maspin gene may contribute to the recuperation of biological functions linked to FR901228 such as an inhibitory effect on tumor angiogenesis and cell invasion. These results indicate that maspin and its target genes may be excellent leads for future studies on the potential benefits of FR901228, a HDAC inhibitor, in cancer therapy.

Original languageEnglish
Pages (from-to)597-603
Number of pages7
JournalOral Oncology
Volume40
Issue number6
DOIs
Publication statusPublished - Jul 2004

Fingerprint

decitabine
Histone Deacetylase Inhibitors
Mouth Neoplasms
Gene Expression
Cell Line
SERPIN-B5
romidepsin
Neoplasms
Messenger RNA

Keywords

  • 5-Aza-2-deoxycytidine
  • FR901228
  • Maspin
  • Methylation

ASJC Scopus subject areas

  • Oncology

Cite this

Effects of demethylating agent 5-aza-2′-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines. / Murakami, Jun; Asaumi, Jun-Ichi; Maki, Yuu; Tsujigiwa, Hidetsugu; Kuroda, Masahiro; Nagai, Noriyuki; Yanagi, Yoshinobu; Inoue, Tetsuyoshi; Kawasaki, Shoji; Tanaka, Noriaki; Matsubara, Nagahide; Kishi, Kanji.

In: Oral Oncology, Vol. 40, No. 6, 07.2004, p. 597-603.

Research output: Contribution to journalArticle

Murakami, Jun ; Asaumi, Jun-Ichi ; Maki, Yuu ; Tsujigiwa, Hidetsugu ; Kuroda, Masahiro ; Nagai, Noriyuki ; Yanagi, Yoshinobu ; Inoue, Tetsuyoshi ; Kawasaki, Shoji ; Tanaka, Noriaki ; Matsubara, Nagahide ; Kishi, Kanji. / Effects of demethylating agent 5-aza-2′-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines. In: Oral Oncology. 2004 ; Vol. 40, No. 6. pp. 597-603.
@article{db512bfa9f904ada926665a38e208689,
title = "Effects of demethylating agent 5-aza-2′-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines",
abstract = "Maspin, which belongs to the serine protease inhibitor (serpin) superfamily, has been proposed as a potent tumor suppressor that inhibits cell motility, invasion, angiogenesis, and metastasis. In the present study, we examined the effects of 5-aza-2′-deoxycytidine (5-aza-dC), a demethylating agent, and FR901228, a histone deacetylase (HDAC) inhibitor, on maspin expression in oral cancer cell lines. The expression levels of maspin mRNA were divided into two groups, which was the maspin low-expressed and high-expressed cell lines in the 12 oral cancer cell lines. The maspin promoter contained only a few methylated CpG sites in the maspin low-expressed cell lines. Moreover, the methylation status was not altered after 5-aza-dC treatment. However, the transcription of the maspin gene was clearly increased following 5-aza-dC treatment in a number of oral cancer cell lines. These results imply that an action of 5-aza-dC is separate from induction of promoter demethylation. Treatment with FR901228 resulted in a time-dependent stimulation of the re-expression of maspin mRNA as early as 4 h after treatment in the maspin downregulated cells. The re-expression of the maspin gene may contribute to the recuperation of biological functions linked to FR901228 such as an inhibitory effect on tumor angiogenesis and cell invasion. These results indicate that maspin and its target genes may be excellent leads for future studies on the potential benefits of FR901228, a HDAC inhibitor, in cancer therapy.",
keywords = "5-Aza-2-deoxycytidine, FR901228, Maspin, Methylation",
author = "Jun Murakami and Jun-Ichi Asaumi and Yuu Maki and Hidetsugu Tsujigiwa and Masahiro Kuroda and Noriyuki Nagai and Yoshinobu Yanagi and Tetsuyoshi Inoue and Shoji Kawasaki and Noriaki Tanaka and Nagahide Matsubara and Kanji Kishi",
year = "2004",
month = "7",
doi = "10.1016/j.oraloncology.2003.12.008",
language = "English",
volume = "40",
pages = "597--603",
journal = "Oral Oncology",
issn = "1368-8375",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Effects of demethylating agent 5-aza-2′-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines

AU - Murakami, Jun

AU - Asaumi, Jun-Ichi

AU - Maki, Yuu

AU - Tsujigiwa, Hidetsugu

AU - Kuroda, Masahiro

AU - Nagai, Noriyuki

AU - Yanagi, Yoshinobu

AU - Inoue, Tetsuyoshi

AU - Kawasaki, Shoji

AU - Tanaka, Noriaki

AU - Matsubara, Nagahide

AU - Kishi, Kanji

PY - 2004/7

Y1 - 2004/7

N2 - Maspin, which belongs to the serine protease inhibitor (serpin) superfamily, has been proposed as a potent tumor suppressor that inhibits cell motility, invasion, angiogenesis, and metastasis. In the present study, we examined the effects of 5-aza-2′-deoxycytidine (5-aza-dC), a demethylating agent, and FR901228, a histone deacetylase (HDAC) inhibitor, on maspin expression in oral cancer cell lines. The expression levels of maspin mRNA were divided into two groups, which was the maspin low-expressed and high-expressed cell lines in the 12 oral cancer cell lines. The maspin promoter contained only a few methylated CpG sites in the maspin low-expressed cell lines. Moreover, the methylation status was not altered after 5-aza-dC treatment. However, the transcription of the maspin gene was clearly increased following 5-aza-dC treatment in a number of oral cancer cell lines. These results imply that an action of 5-aza-dC is separate from induction of promoter demethylation. Treatment with FR901228 resulted in a time-dependent stimulation of the re-expression of maspin mRNA as early as 4 h after treatment in the maspin downregulated cells. The re-expression of the maspin gene may contribute to the recuperation of biological functions linked to FR901228 such as an inhibitory effect on tumor angiogenesis and cell invasion. These results indicate that maspin and its target genes may be excellent leads for future studies on the potential benefits of FR901228, a HDAC inhibitor, in cancer therapy.

AB - Maspin, which belongs to the serine protease inhibitor (serpin) superfamily, has been proposed as a potent tumor suppressor that inhibits cell motility, invasion, angiogenesis, and metastasis. In the present study, we examined the effects of 5-aza-2′-deoxycytidine (5-aza-dC), a demethylating agent, and FR901228, a histone deacetylase (HDAC) inhibitor, on maspin expression in oral cancer cell lines. The expression levels of maspin mRNA were divided into two groups, which was the maspin low-expressed and high-expressed cell lines in the 12 oral cancer cell lines. The maspin promoter contained only a few methylated CpG sites in the maspin low-expressed cell lines. Moreover, the methylation status was not altered after 5-aza-dC treatment. However, the transcription of the maspin gene was clearly increased following 5-aza-dC treatment in a number of oral cancer cell lines. These results imply that an action of 5-aza-dC is separate from induction of promoter demethylation. Treatment with FR901228 resulted in a time-dependent stimulation of the re-expression of maspin mRNA as early as 4 h after treatment in the maspin downregulated cells. The re-expression of the maspin gene may contribute to the recuperation of biological functions linked to FR901228 such as an inhibitory effect on tumor angiogenesis and cell invasion. These results indicate that maspin and its target genes may be excellent leads for future studies on the potential benefits of FR901228, a HDAC inhibitor, in cancer therapy.

KW - 5-Aza-2-deoxycytidine

KW - FR901228

KW - Maspin

KW - Methylation

UR - http://www.scopus.com/inward/record.url?scp=11144356238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144356238&partnerID=8YFLogxK

U2 - 10.1016/j.oraloncology.2003.12.008

DO - 10.1016/j.oraloncology.2003.12.008

M3 - Article

C2 - 15063388

AN - SCOPUS:11144356238

VL - 40

SP - 597

EP - 603

JO - Oral Oncology

JF - Oral Oncology

SN - 1368-8375

IS - 6

ER -